Works matching IS 15228517 AND DT 2017 AND VI 19 AND IP 4
Results: 27
“What to eat or what not to eat—that is still the question” - Reply.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 596, doi. 10.1093/neuonc/now291
- By:
- Publication type:
- Article
Reply to Freyschlag et al.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 598, doi. 10.1093/neuonc/now296
- By:
- Publication type:
- Article
Corrigenda.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 601, doi. 10.1093/neuonc/nox023
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 600, doi. 10.1093/neuonc/nox031
- Publication type:
- Article
Comment on: Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 597, doi. 10.1093/neuonc/now289
- By:
- Publication type:
- Article
What to eat or what not to eat--that is still the question.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 595, doi. 10.1093/neuonc/now284
- By:
- Publication type:
- Article
Radiation injury versus malignancy after stereotactic radiosurgery for brain metastases: impact of time-dependent changes in lesion morphology on MRI.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 586, doi. 10.1093/neuonc/now193
- By:
- Publication type:
- Article
Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 576, doi. 10.1093/neuonc/now234
- By:
- Publication type:
- Article
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 567, doi. 10.1093/neuonc/now185
- By:
- Publication type:
- Article
Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 558, doi. 10.1093/neuonc/now184
- By:
- Publication type:
- Article
Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 546, doi. 10.1093/neuonc/now231
- By:
- Publication type:
- Article
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 535, doi. 10.1093/neuonc/now235
- By:
- Publication type:
- Article
A novel NFIA-NFκB feed-forward loop contributes to glioblastoma cell survival.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 524, doi. 10.1093/neuonc/now233
- By:
- Publication type:
- Article
REST represses miR-124 and miR-203 to regulate distinct oncogenic properties of glioblastoma stem cells.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 514, doi. 10.1093/neuonc/now232
- By:
- Publication type:
- Article
Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 503, doi. 10.1093/neuonc/now230
- By:
- Publication type:
- Article
Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 493, doi. 10.1093/neuonc/now179
- By:
- Publication type:
- Article
Leptomeningeal metastases: a RANO proposal for response criteria.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 484, doi. 10.1093/neuonc/now183
- By:
- Publication type:
- Article
FGFR-TACC gene fusions in human glioma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 475, doi. 10.1093/neuonc/now240
- By:
- Publication type:
- Article
Point/counterpoint: randomized versus singlearm phase II clinical trials for patients with newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 469, doi. 10.1093/neuonc/nox030
- By:
- Publication type:
- Article
Novel Strategy for Targeted Therapies: Brain Metastases.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 468, doi. 10.1093/neuonc/nox032
- By:
- Publication type:
- Article
Chimeric Antigen Receptor T Cells in Glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 467, doi. 10.1093/neuonc/nox032
- By:
- Publication type:
- Article
Endocrine Evaluation in Pediatric Brain Tumor Patients: Who, What, When, and Why?
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 467, doi. 10.1093/neuonc/nox032
- By:
- Publication type:
- Article
NAD<sup>+</sup>-dependent Transcriptional Networks Promote Self-renewal and Tumorigenicity in Glioblastoma Stem Cells.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 466, doi. 10.1093/neuonc/nox032
- By:
- Publication type:
- Article
Shifting the balance of power? The combination of oncolytic virotherapy and immune checkpoint blockade for glioblastoma treatment.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 463, doi. 10.1093/neuonc/nox011
- By:
- Publication type:
- Article
FGFR-TACC approaches the first turn in the race for targetable GBM mutations.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 461, doi. 10.1093/neuonc/nox005
- By:
- Publication type:
- Article
How can we develop therapies for glioblastoma more efficiently? Randomized versus single-arm studies.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 459, doi. 10.1093/neuonc/nox041
- By:
- Publication type:
- Article
Analyzing Thoroughly, Revealing Therapy: New Biologic and Therapeutic Insights into ATRT.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 146, doi. 10.1093/neuonc/nox032
- By:
- Publication type:
- Article